Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
274M
Number of holders
327
Total 13F shares, excl. options
266M
Shares change
+1.54M
Total reported value, excl. options
$5.63B
Value change
+$39M
Put/Call ratio
1.18
Number of buys
153
Number of sells
-164
Price
$21.14

Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q3 2021

388 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q3 2021.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 327 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 266M shares of 274M outstanding shares and own 97.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (31.9M shares), VANGUARD GROUP INC (30.1M shares), FMR LLC (18.8M shares), RENAISSANCE TECHNOLOGIES LLC (17.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (17.2M shares), JPMORGAN CHASE & CO (11.4M shares), Meditor Group Ltd (10.7M shares), STATE STREET CORP (10.6M shares), FARALLON CAPITAL MANAGEMENT LLC (9.66M shares), and Polar Capital Holdings Plc (4.07M shares).
This table shows the top 327 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.